These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8981147)

  • 1. Effects of daily low dose mifepristone on endometrial maturation and proliferation.
    Cameron ST; Critchley HO; Thong KJ; Buckley CH; Williams AR; Baird DT
    Hum Reprod; 1996 Nov; 11(11):2518-26. PubMed ID: 8981147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
    Cameron ST; Critchley HO; Buckley CH; Kelly RW; Baird DT
    Fertil Steril; 1997 Jun; 67(6):1046-53. PubMed ID: 9176442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial effects of RU486 in primates--antiproliferative action despite signs of estrogen action and increased cyclin-B expression.
    Heikinheimo O; Hsiu JG; Gordon K; Kim S; Williams RF; Gibbons WE; Hodgen GD
    J Steroid Biochem Mol Biol; 1996 Oct; 59(2):179-90. PubMed ID: 9010333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose mifepristone inhibits endometrial proliferation and up-regulates androgen receptor.
    Narvekar N; Cameron S; Critchley HO; Lin S; Cheng L; Baird DT
    J Clin Endocrinol Metab; 2004 May; 89(5):2491-7. PubMed ID: 15126582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase.
    Gemzell-Danielsson K; Svalander P; Swahn ML; Johannisson E; Bygdeman M
    Hum Reprod; 1994 Dec; 9(12):2398-404. PubMed ID: 7714164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of post-ovulatory administration of onapristone on the developmnent of a secretory endometrium.
    Cameron ST; Critchley HO; Buckley CH; Chard T; Kelly RW; Baird DT
    Hum Reprod; 1996 Jan; 11(1):40-9. PubMed ID: 8671154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial effects of long-term low-dose administration of RU486.
    Murphy AA; Kettel LM; Morales AJ; Roberts V; Parmley T; Yen SS
    Fertil Steril; 1995 Apr; 63(4):761-6. PubMed ID: 7890059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term treatment with low-dose mifepristone on the endometrium.
    Baird DT; Brown A; Critchley HO; Williams AR; Lin S; Cheng L
    Hum Reprod; 2003 Jan; 18(1):61-8. PubMed ID: 12525442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of progesterone antagonists and progesterone receptor modulators in contraception.
    Spitz IM; Van Look PF; Coelingh Bennink HJ
    Steroids; 2000; 65(10-11):817-23. PubMed ID: 11108893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms.
    Neulen J; Williams RF; Breckwoldt M; Chwalisz K; Baulieu EE; Hodgen GD
    Hum Reprod; 1996 Jul; 11(7):1533-7. PubMed ID: 8671500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The possible use of antiprogestins for contraception.
    Bygdeman M; Danielsson KG; Swahn ML
    Acta Obstet Gynecol Scand Suppl; 1997; 164():75-7. PubMed ID: 9225644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low weekly doses of mifepristone on ovarian function and endometrial development.
    Gemzell-Danielsson K; Westlund P; Johannisson E; Swahn ML; Bygdeman M; Seppälä M
    Hum Reprod; 1996 Feb; 11(2):256-64. PubMed ID: 8671205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo.
    Critchley HO; Tong S; Cameron ST; Drudy TA; Kelly RW; Baird DT
    J Reprod Fertil; 1999 Mar; 115(2):389-95. PubMed ID: 10434946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible suppression of menstruation with progesterone antagonists in rhesus macaques.
    Slayden OD; Chwalisz K; Brenner RM
    Hum Reprod; 2001 Aug; 16(8):1562-74. PubMed ID: 11473944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive use of antiprogestin.
    Bygdeman M; Danielsson KG; Marions L; Swahn ML
    Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):103-7. PubMed ID: 10427485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of various doses of mifepristone on endometrial leukaemia inhibitory factor expression in the midluteal phase--an immunohistochemical study.
    Danielsson KG; Swahn ML; Bygdeman M
    Hum Reprod; 1997 Jun; 12(6):1293-7. PubMed ID: 9222019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mulatta).
    Slayden OD; Brenner RM
    J Clin Endocrinol Metab; 1994 Feb; 78(2):440-8. PubMed ID: 8106633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.